Pharmaceutical Raw Material Drug Powder CAS 41100-52-1 Memantine Hydrochloride HCl

China Pharmaceutical Raw Material Drug Powder CAS 41100-52-1 Memantine Hydrochloride HCl, Find details about China Memantine, Memantine HCl from Pharmaceutical Raw Material Drug Powder CAS 41100-52-1 Memantine Hydrochloride HCl

Basic Info.

Model NO.

Memantine

Name

Memantine HCl

C12h21n.HCl

CAS

19982-08-2

Trademark

Transport Package

Drum

Specification

99%

Origin

China

HS Code

2904201000

Model NO.

Memantine

Name

Memantine HCl

C12h21n.HCl

CAS

19982-08-2

Trademark

Transport Package

Drum

Specification

99%

Origin

China

HS Code

2904201000

Product Desciption

Pharmaceutical Raw Material Drug Powder CAS 41100-52-1 Memantine Hydrochloride HCl

Name : MEMANTINE HYDROCHLORIDE/MEMANTINE HCL
Synonyms : 9H-Fluoren-9-ol
CAS : 19982-08-2
Molecular Formula: C12H21N.HCl
Molecular Weight: 179.3
EINECS: 690-724-9
Properties:white crystalline powder
Capacity: 500kgs per month
Source: synthetic
Purity (HPLC) >99.0%
Packing: As per client's requirements
Minimum Order Quantity: 1kg
Storage: Keep it in a Dry and Sealed Place for 2 years

What is Memantine?
Memantine hydrochloride is a raw material. It should be prescribed by experienced doctors in the diagnosis and treatment of Alzheimer's dementia and guided by patients. Treatment can only begin when there are caregivers around the patient who regularly supervise the patient's medication. Dementia should be diagnosed in accordance with current diagnostic criteria and guidelines.

Memantine Benefits
Memantine HCl is the HCl form of Memantine. Memantine is a well- known neuroprotective drug used for the treatment of Alzheimer's disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European.

The development of Alzheimer's disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity.

Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs).

Memantine is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington's disease, ALS and movement disorders, among other.

Memantine Mode of Action
Used in medicine, health products, food, beverage, cosmetics, biological and chemical reagents and other industries.This drug hasn't been involved in any human clinicial testing or trials therefore a safe dosage and any potential side effects have not been established. Pharmaceutical Raw Material Drug Powder CAS 41100-52-1 Memantine Hydrochloride HCl